MedTrace Logo

Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety

NCT04377074 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2880

Last updated 2020-05-06

No results posted yet for this study

Summary

This study seeks to investigate the levels of parental stress across different demographic subgroups in the general parental population during the strict social distancing government-initiated non-pharmacological interventions (NPI's) related to the COVID-19 pandemic. The study also seeks to examine the predictors of parental stress rates related to these non-pharmacological interventions (NPI's). In addition, the research will investigate the association between parental stress associated and psychopathology symptoms (i.e., depression and generalized anxiety).

The aim of the project is to:

* Inform the policymakers, the general public, scientists, and health practitioners about the psychological associations of the COVID-19-related government-initiated measures on parental stress, with special focus on the school and kindergarten lockdowns.
* Provide a foundation for policymakers and health-care professionals to employ interventions that protect families against possibly increased psychological stressors.
* Help policymakers and healthcare professionals to better understand the association of demographic variables and other predictors on parental stress and parent-child dysfunction, which information necessary for evaluating the psychological impact of NPIs on parental stress and thus the framework under which decisions about school/kindergarten lockdowns are made.

Conditions

Sponsors & Collaborators

  • Modum Bad

    collaborator OTHER

  • Oslo Metropolitan University

    collaborator OTHER

  • University of Bergen

    collaborator OTHER

  • University of Oslo

    lead OTHER

Principal Investigators

  • Miriam Sinkerud Johnson, PhD · Oslo Metropolitan University

  • Nora Paulsen Skjerdingstad · University of Bergen

  • Omid Ebrahimi · University of Oslo & Modum Bad

  • Asle Hoffart, PhD · Modum Bad & University of Oslo

  • Sverre Urnes Johnson, PhD · University of Oslo & Modum Bad

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-31
Primary Completion
2020-04-07
Completion
2020-04-07

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04377074 on ClinicalTrials.gov